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Edited by Irmgard SinningAbstract The formation of transition state mimics of phos-
phoryl transfer reactions with the metal oxoanion vanadate is a
powerful technique in macromolecular crystallography. The
tendency of vanadate to form pentacovalent complexes exhibit-
ing trigonal bipyramidal geometry makes this compound a close
approximation of the transition state for such reactions. In many
cases, vanadate complexes provide the most accurate visualiza-
tion of the transition state that can be reasonably achieved. A
survey of the Protein Data Bank reveals that a relatively small
number of structures (39, representing 23 unique proteins)
include vanadate, yet these structures represent four of the six
E.C. categories of enzymes, and were obtained in crystals with
pH values ranging from 5.0 to 7.8. Vanadate has additional
advantages over other compounds such as aluminum ﬂuoride,
beryllium ﬂuoride and nitrate used for visualization of transition
state mimics in that vanadate readily forms covalent bonds with
a variety of ligands and has produced a wider variety of
transition state mimics. Given the hundreds of crystal structures
that have been solved for phosphoryl transfer enzymes, it is
surprising that vanadate has not been used more frequently for
visualization of transition state analogs. We propose that an
opportunity exists for vanadate to become a more commonly
utilized component of the macromolecular crystallographer’s
toolbox.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The transition metal oxoanion vanadate (VO34 ) is a close
structural and chemical mimic of phosphate. In addition,
vanadate can be easily derivatized in aqueous solution with a
variety of ligands and tends to adopt a pentacoordinate, tri-
gonal bipyramidal geometry around the central vanadium (V)
atom. These features have led to the proposal that vanadate
can act as an analog for the conformation of the phosphate
group at the transition state expected for phosphoryl transfer
[1,2]. As would be expected for such a transition state mimic,* Corresponding author. Fax: +1-206-685-7002.
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doi:10.1016/j.febslet.2004.10.022vanadate is a potent inhibitor of many phosphoryl transfer
enzymes [3,4]. This mimicry has been observed many times in
X-ray crystal structures of enzymes complexed with vanadate.
These structures have provided a wealth of insight into cata-
lytic mechanism and substrate binding modes. The present
review will focus mainly on technical and scientiﬁc aspects of
the use of vanadate in macromolecular crystallography.
Although the concept of vanadate as a phosphoryl transfer
transition state has become very widely accepted [5], it should
be noted that this view has been critically evaluated [6,7].
Theoretical studies [6] concluded that V–O bonds are consid-
erably less polar (smaller electrostatic potential) than expected
for the corresponding P–O bonds in a true transition state.
Additionally, bond angles in enzyme–vanadate complexes
have been observed to diﬀer from the corresponding predicted
bond angles in ideal trigonal bipyramidal transition states. For
example, although the angle between the two apical bonds in
the transition state should be 180, distorted angles of as little
as 150.5 have been observed [8]. Another consideration is that
phosphoryl transfer is thought to proceed via diﬀerent mech-
anisms in diﬀerent enzymes. Monoester hydrolysis is often
thought to occur by a ‘‘dissociative’’ mechanism, where the
bond between phosphorus and substrate completely breaks
before the bond to the nucleophile forms, whereas phospho-
diester cleavage is thought to occur by a more ‘‘associative’’
mechanism where a partial bond forms between phosphorus
and the nucleophile before the bond to the substrate is com-
pletely broken [9]. This view of phosphoryl transfer mecha-
nisms, however, is still an active area of debate [10,11]. At any
rate, vanadate has been observed to form pentacoordinate
complexes with a variety of enzymes and may provide infor-
mation about transition states in either dissociative or asso-
ciative cases.
Regardless of any remaining controversies, vanadate re-
mains an excellent practical option for approximation of
phosphate transition states. The closest chemical approxima-
tion of such a transition state is a class of pentacovalent
phosphorus compounds known as phosphoranes. Unfortu-
nately, hydroxy phosphoranes that are analogous to the
transition state for ester or phosphodiester hydrolysis are
generally unstable compounds. Commonly, stable phosphor-
anes can only be obtained in cases where several ester linkages
stabilize the complex [12]. A survey of phosphoranes in the
Cambridge Structural Database reveals that the databaseblished by Elsevier B.V. All rights reserved.
316 D.R. Davies, W.G.J. Hol / FEBS Letters 577 (2004) 315–321contains no structures of pentacovalent phosphorane struc-
tures with fewer than four non-hydroxy ligands and only a
handful of structures that possess a single hydroxy ligand. A
phosphorane intermediate bound to an enzyme has only been
visualized serendipitously in two unusual crystal structures (in
phospholipase D, PDB code 1V0Y, [13], and in a controver-
sialb-phosphoglucomutase structure [14,15] PDB code 1O08
[16]).
A variety of anions have been employed for the visualization
of phosphoryl transfer enzymes as transition state mimics or as
mimics of phosphorylated states. Metal oxoanions such
as molybdate [17] and tungstate [18] have also been employed
as phosphate mimics in place of vanadate. Vanadium, with an
atomic number of 23, however, possesses a number of elec-
trons that are much closer to phosphorus (atomic number 15)
than molybdenum (atomic number 42) or tungsten (atomic
number 74). Tungsten is moreover such a heavy element that
the resulting electron density can obscure surrounding atoms,
making map interpretation diﬃcult, particularly at medium to
lower resolution [18]. Furthermore, tungstate has a propensity
to form hexacoordinate, octahedral complexes that are not
accurate transition state mimics [18,19]. Another advantage of
vanadate over other metal oxoanions is the apparent relative
ease with which vanadate has been observed to derivatize with
other molecules. In one recent case, this property has allowed
the self-assembly of a quaternary complex around vanadate
that was a mimic for the transition state for cleavage of a
phosphodiester substrate, with a histidine, tyrosine and a ri-
bose as ligands [20,21].
Aluminum ﬂuoride, beryllium ﬂuoride and nitrate ion have
also been employed in macromolecular crystallography as
phosphate analogs [22,23]. The ions AlF4 , BeF

3 , and NO

3
have a propensity to occupy phosphate-binding sites because
they approximate the shape and charge of phosphate. How-
ever aluminum ﬂuoride and beryllium ﬂuoride are not
isosteric with the trigonal planar PO3 moiety of a phospho-
transfer transition state in a phosphoryl transfer reaction:
aluminum ﬂuoride is a square planar ion and the beryllium
ﬂuoride ion is non-planar. Nitrate ion is the best steric mimic
for the PO3 moiety, but this compound lacks vanadate’s
ability to form covalent bonds. In all cases in the PDB to
date, these compounds either mimic the c phosphate during
hydrolysis of nucleotide triphosphates, or mimic phosphory-
lated residues on proteins. Although these compounds have
been useful for unraveling catalytic mechanisms, particularly
in the case of a series of structures including aluminum ﬂuo-
ride, beryllium ﬂuoride and vanadate with myosin-ADP
[22,24], vanadate appears to have several advantages as a
transition state mimic.2. Overview of enzyme–vanadate complexes
Of the 27 112 macromolecular structures in the Protein
Data Bank as of September 7, 2004 [25], only 39 include
protein-vanadate complexes (see Table 1). This collection of
structures includes 23 distinct proteins that encompass 19
unique E.C. numbers. These enzymes represent classes 1, 2, 3
and 5 of the six E.C. groups (categorized as oxidoreductases,
transferases, hydrolases and isomerases, respectively). Of
these 39 structures, all but six exhibited covalent bonds (de-
ﬁned by bond length) to vanadate and 21 have been classiﬁedas representing transition state analogs (although the case of
ribonuclease A has been the subject of some debate [6,26,27]).
All of the vanadate complexes classiﬁed as transition state
mimics exhibit trigonal bipyramidal or distorted trigonal bi-
pyramidal geometry around the vanadium, and at least one
covalent linkage exists between the vanadium atom and at-
oms of the enzyme or substrate molecules as will be discussed
further below.
The structures classiﬁed as not representing transition state
mimics fall under one of three categories: Either tetrahedral
(presumably VO34 ) vanadate was bound in a non-covalent
fashion [28–31]; or vanadate had formed a cyclic covalent
complex with the ribose of a nucleotide that did not represent a
possible transition state [32,33]; or the vanadate was present as
part of an oligomeric vanadate complex that was incapable of
forming a transition state mimic [34,35] (see below for a dis-
cussion of vanadate polymerization).
Nine additional structures listed in Table 1 are examples of
fungal haloperoxidases, which use a covalently bound vana-
date cofactor to catalyze reactions that halogenate organic
compounds. The vanadate moiety in the haloperoxidases was
not added by the crystallographers, but rather is native to the
enzyme. It is interesting to note that phosphatase activity can
be catalyzed by apohaloperoxidases, and phosphatases can be
converted to haloperoxidases in the presence of vanadate and
hydrogen peroxide. Thus, the haloperoxidases can be thought
of vanadate-inhibited (i.e., transition state analog-containing)
versions of phosphatase enzymes. We will not comment on
these cases here further.3. Technical considerations
Perhaps, the largest technical challenge in working with
vanadate is overcoming the compound’s tendency to oligo-
merize to form dimeric and polymeric species in solution at
neutral pH [36,37]. The predominant species of vanadate (V)
from pH 2 to 6 is a decameric species (V10O
6
28 ) that exhibits a
bright orange-yellow color. Obviously, this nearly 1 kDa
cluster is too large to form an enzyme–vanadate complex ca-
pable of providing insight into phosphoryl transfer reactions.
At alkaline pH, the monomeric species of vanadate is more
prevalent, and many researchers have prepared ‘‘activated’’
solutions of monomeric orthovanadate using a method similar
to that described by Gordon [38]. In short, this method in-
volves adjusting the pH of a stock solution of sodium ortho-
vanadate above 10 and heating near 100 C until the solution is
clear and colorless.
Of course, the vast majority of proteins require a pH below
10 for crystallization, so the use of very high pH values for
the formation of enzyme–vanadate complexes is impractical.
Indeed, the structures of enzymes complexed with monomeric
vanadate reported in the Protein Data Bank, excluding the
haloperoxidases, which use vanadate as a cofactor, came
from crystals that were grown at pH values ranging from 5.0
to 7.8. Given the relatively small number of vanadate com-
plexes in the Protein Data Bank, this pH range should not
necessarily be considered limiting. Nevertheless, this pH
range covers approximately 50% of the entries in the Bio-
logical Macromolecule Crystallization Database [39], which
lists crystallization conditions for a subset of entries in the
Protein Data Bank. It appears that the use of an ‘‘activated’’
Table 1
Summary of enzyme–vanadate complexes in the Protein Data Bank
Protein TS
mimic?
# bonds
to V
Ligands pH Res.
(A)
E.C.
number
Enzyme
Type
PDB ID Ref.
Tyrosyl-DNA
phosphodiesterase
(Tdp1)
Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.3 3.1.4.-
(unclassiﬁed)
Phosphodiesterase 1NOP [21]
Tdp1 Y 3 Ne of His 263,
O1 and O2 of
glycerol
7.8 2.05 3.1.4.- Phosphodiesterase 1MU9 [18]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 1.70 3.1.4.- Phosphodiesterase 1RFF [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.20 3.1.4.- Phosphodiesterase 1RFI [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.10 3.1.4.- Phosphodiesterase 1RG1 [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.10 3.1.4.- Phosphodiesterase 1RG2 [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.00 3.1.4.- Phosphodiesterase 1RGT [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.22 3.1.4.- Phosphodiesterase 1RGU [20]
Tdp1 Y 3 Ne of His263,
OH of tyrosine,
O30 of DNA
7.8 2.30 3.1.4.- Phosphodiesterase 1RHO [20]
Scallop
Myosin S1
Y 1 b-Phosphate of ADP 6.0 2.6 3.6.4.1 ATPase 1QVI [42]
Myoe Motor domain Y 1 b-Phosphate of ADP 7.2 3.0 3.6.4.1 ATPase 1LKX [44]
Phosphoglucomutase Y 2 Oc of Ser116,
O6 of Glucose a-1-
phosphate-
6-vanadate
6.5 2.7 2.7.5.1 Phospho-transferase 1C4G [45]
Scallop
Myosin S1
Y 1 b-Phosphate of ADP 6.0 4.2 3.6.4.1 ATPase 1DFL [41]
Alkaline
phosphatase
Y 1 Oc Ser102 7.5 1.9 3.1.3.1 Phosphatase 1B8J [17]
Estrogen
sulfotransferase
Y 1 Phosphate of
adenosine 30,50
diphosphate
6.5 2.1 2.8.2.4 Sulfotransferase 1BO6 [46]
Dictyostelium myosin Y 1 b-Phosphate of ADP 7.0 1.9 3.6.4.1 ATPase 1VOM [24]
Ribonuclease A Y 2 O20 and O30 of uridine 6.2 1.3 3.1.27.5 Ribonuclease 1RUV [26]
Ribonuclease A Y 2 O20 and O30 of uridine 6.2 1.3 3.1.27.5 Ribonuclease 6RSA [26]
Rat acid phosphatase Y 1 Ne of His12 (nucleophile
in enzyme)
5.4 3.0 3.1.3.2 Phosphatase 1RPT [47]
Hairpin ribozyme Y 3 020 and 030 of G +1,
+O50 of A-1
N.R 2.2 3.1.27. - Ribonuclease
(ribozyme)
1M5O [40]
PhoE Y 1+ Trivanadate bound:
One to Ne of His10
(nucleophile), diﬀerent
vanadate to Glu83.
5.0 2.0 5.4.2.1 1H2F [48]
KIF1A Kinesin Y 1 b-Phosphate of ADP 7.0 2.24 3.6.4.4 ATPase 1VFZ [53]
Cyclic nucleotide
phosphodiesterase
N 2 O20 and O30 of uridine
Substrate mimic
5.0 2.4 3.1.4.17 Phosphodi-esterase 1JH7 [32]
APS kinase N 2+ O20, O30 of ribose of ADP,
plus 30OH of symmetry-
related ADP
6.5 1.43 2.7.1.25 Phospho-transferase 1M7G [33]
SurE protein
(phosphatase)
N 0 Tetrahedral vanadate
bound non-covalently
7.5 1.9 3.1.3.- Phosphatase 1J9L [28]
Human cyclin
dependent kinase
N 0 Partially disordered meta-
vanadate (V10O28) bound
non-covalently
7.4 2.9 2.7.1.37 Kinase 1DKT [35]
Ribonuclease T1 N 0 Tetrahedral vanadate
bound non-covalently
5.0 1.8 3.1.27.3 Ribonuclease 3RNT [29]
Phosphoglycerate
mutase
N 0 Tetravanadate bound
non-covalently
8.75 1.3 5.4.2.1 Mutase 1E59 [30]
Bacterial abc
transporter
N 0 n-cyclo-tetrameta-
vanadate bound non-
covalently
8.0 3.2 3.6.3.33 ATPase 1L7V [34]
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Table 1 (continued)
Protein TS
mimic?
#
bonds
to V
Ligands pH Res.
(A)
E.C.
number
Enzyme
Type
PDB ID Ref.
C3 exoenzyme from
C. botulinum
N 0 Tetrahedral vanadate and
n-cyclo-tetrametavanadate
bound non-covalently
5.5 1.89 2.4.2.30 NAD(+) ADP-
ribosyltransferase
1UZI [31]
Haloperoxidase N 1 Ne of His486 8.3 2.05 1.11.1.10 Haloperoxidase 1QI9 [49]
Chloroperoxidase N 1 Ne of His496 8.0 2.1 1.11.1.10 Chloroperoxidase 1VNC [50]
Chloroperoxidase N 1 Ne of His496 8.0 2.03 1.11.1.10 Chloroperoxidase 1IDQ [51]
Chloroperoxidase N 1 Ne of His496 8.0 2.24 1.11.1.10 Chloroperoxidase 1IDU [51]
Chloroperoxidase
(R360A)
N 1 Ne of His496 8.0 2.35 1.11.1.10 Chloroperoxidase 1VNF [52]
Chloroperoxidase
(D292A)
N 1 Ne of His496 8.0 2.15 1.11.1.10 Chloroperoxidase 1VNE [52]
Chloroperoxidase
(H404A)
N 1 Ne of His496 8.0 2.2 1.11.1.10 Chloroperoxidase 1VNG [52]
Chloroperoxidase
(H496A)
N 1 Ne of His496 8.0 2.11 1.11.1.10 Chloroperoxidase 1VNH [52]
Chloroperoxidase N 1 Ne of His496 8.0 2.11 1.11.1.10 Chloroperoxidase 1VNI [52]
Summary of protein-vanadate complexes in the Protein Data Bank. The ‘‘TS mimic?’’ identiﬁes whether or not the authors of the original citation
have identiﬁed the crystal structure as a transition state mimic. ‘‘#bonds to V’’ records the number of covalent bonds between vanadate and other
(non-water oxygen) ligands, which are listed in the ‘‘ligands’’ column. The pH column lists the reported pH for crystallization of the complex.
Resolution is the resolution of the published crystal structure. The E.C. number/enzyme type columns record the E.C. classiﬁcation number and
common name of the enzyme, respectively. In cases where enzymes have not been assigned an E.C. number, the fourth position is marked with a
dash. PDB ID lists the accession number in the RCSB Protein Data Bank (www.rcsb.org/pdb).
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producing complexes with protein solutions buﬀered near
neutral pH (as in [21,24,40]) because monomeric vanadate
may be able to form an enzyme–vanadate complex before a
prohibitive amount of polymerization takes place. However,
there have been instances where very alkaline solutions of
vanadate have not been necessary to achieve crystal struc-
tures of vanadate complexes, such as the case of alkaline
phosphatase ([17] see below).4. Insights from speciﬁc vanadate complex structures
The ability to visualize a transition state mimic is a
powerful tool for understanding enzyme mechanism. Struc-
tures of transition state analogs can clarify the role of active
site amino acid residues and reveal conformational changes
that may take place in the course of the catalytic cycle.
Enzyme mechanisms sometimes involve dynamic rearrange-
ments of active site residue conformations and/or domain
movements. An ensemble of structures representing diﬀerent
points along a reaction pathway is required for a complete
understanding of an enzyme’s mechanism. For enzymes that
catalyze chemistry on a phosphate group, enzyme–vanadate
complexes have provided crucial insights into the mecha-
nisms of the transferase APS kinase; hydrolases including
ribonuclease T1, the SurE phosphatase, cyclic nucleotide
phosphodiesterase, acid phosphatase, alkaline phosphatase,
myosin, tyrosyl-DNA phosphodiesterase and the hairpin ri-
bozyme; the isomerases phosphoglycerate mutase and PhoE;
and, as a naturally occurring cofactor, the oxidoreductases
chloroperoxidase and haloperoxidase (see Table 1). The four
detailed examples that follow have provided valuable in-
sights into enzyme mechanism, and collectively demonstrate
the ability of vanadate to mimic transition states for en-
zymes involving monoester substrates (which are generallypresumed to follow a ‘‘dissociative’’ mechanism) as well as
diester substrates (presumed to have more ‘‘associative’’
mechanisms).
The vanadate complex with E. coli alkaline phosphatase
[17] was obtained by soaking existing crystals of the enzyme
in a stabilization solution at pH 7.5 that included 100 lM
NH4VO3 from a stock solution prepared at a pH of 8.0.
Even though the vanadate solution was not ‘‘activated’’ to
ensure the predominance of monomeric vanadate, vanadate
was observed in the active site of the resulting crystal
structure. The vanadate moiety adopted trigonal bipyramidal
geometry, with the Oc of Ser102 contributing one apical li-
gand (Fig. 1a). This structure was published as part of a
three-structure series (PDB entries 1HJK, 1ALK and 1B8J )
that also included the enzyme non-covalently bound to in-
organic phosphate and a phosphorylated mutant enzyme.
Taken as a whole, these structures provide strong support for
the role of a bound Zn ion in activating a water molecule for
attack on the phosphoseryl intermediate. Furthermore, the
three structures allow the trajectory of the nucleophilic water
molecule during the hydrolysis of the phosphoseryl interme-
diate to be traced. In a structure of a phosphorylated alka-
line phosphatase H331Q mutant (PDB ID 1HJK), a water
molecule was observed coordinated to Zn1 at a distance of
2.2 A from the Zn and 3.4 A from the phosphate. In the
vanadate complex, this ‘‘activated’’ water molecule is ob-
served as the free oxygen bound at an apical position of
vanadate, 2.4 A from Zn1 and 1.9 A from the vanadium
atom.
Vanadate complexes with the ATPase myosin [24,41,42] also
exhibit trigonal bipyramidal geometry around the vanadium
atom, but there are no covalent linkages directly to the en-
zyme, only one apical ligand to the b-phosphate of ADP is
formed (Fig. 1b). These structures represent a transition state
mimic for the hydrolysis of the c-phosphate from ATP. This
ADP-vanadate structure provided a more realistic transition
Fig. 1. Selected enzyme–vanadate complexes. (a) Alkaline phosphatase–vanadate complex from PDB ID 1B8J [17]. The protein structure is displayed
as a purple ribbon model with amino acid residues displayed as ball-and-stick structures with yellow bonds. The vanadate moiety (Van) is also
displayed as a ball-and-stick structure with blue bonds. Carbon atoms are colored gray; nitrogen, blue; oxygen, red and metal atoms are white.
Vanadate adopts distorted trigonal bipyramidal geometry with Oc of the nucleophilic Ser102 residue comprising one apical ligand and a free oxygen
atom representing the activated water molecule comprising the other apical ligand. (b) Myosin-ADP-Mg-vanadate structure from PDB ID 1VOM
[24]. Coloration for the protein, metal ion and vanadate moieties is the same as in (a) and ADP is displayed as a ball-and-stick structure with red
bonds, and phosphate atoms colored green. (c) Hairpin ribozyme–vanadate structure from PDB ID 1M50 [40]. Atoms are colored as in (b), with
bonds for the ribozyme RNA strand colored yellow and bonds for the substrate RNA strand in red. The vanadate moiety (blue bonds) adopts
distorted trigonal bipyramidal geometry with the ribose of nucleotide A-1 contributing one apical and one equatorial ligand and the 50OH of nu-
cleotide G + 1 contributing the other apical ligand. (d) The quaternary complex around vanadate that mimics the transition state for Tyrosyl-DNA
phosphodiesterase from PDB ID 1NOP [21]. Coloration of the enzyme and vanadate moieties is the same as (a) and (b), with the peptide and DNA
portions of the substrate analog displayed with red bonds.
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aluminum ﬂuoride, where the AlF4 moiety occupied the c-
phosphate binding pocket but adopted a square planar ar-
rangement [24]. The vanadate–ADP complex was trapped in
the active site of myosin prior to crystallization by addition of
2 mM ADP, 3 mM ‘‘activated’’ sodium orthovanadate and 1
mM MgCl2 [24]. The resulting 1.9 A structure of ADP-vana-
date in a truncated Dictyostelium myosin revealed how the
protein ligands and water structure surrounding the c-phos-
phate pocket were oriented to stabilize a water molecule in an
appropriate position for in-line nucleophilic attack on the c-
phosphorus of ATP [24]. Beyond the active site of myosin, the
vanadate–ADP structures also captured an important snap-
shot of conformational changes that play a role in the trans-
duction of the chemical energy of hydrolysis of ATP into
mechanical movement.
The ability of vanadate to readily derivatize and accept
many diﬀerent ligands was demonstrated in a stabilized tran-
sition state mimic of the hairpin ribozyme, where a vanadate in
the active site formed three covalent bonds with surroundingribonucleotides (Fig. 1c). This complex was obtained by a
slight modiﬁcation of known crystallization conditions with an
addition of an alkaline (above pH 10) stock solution of
NH4VO3 (Adrian Ferre-D’Amare, personal communication,
and [40]). In the structure, one apical and one equatorial ligand
were contributed by the 20 and 30 oxygens of one ribonucleo-
tide and represented the attacking nucleophile and the non-
cleaved bridging oxygen, respectively. The other apical ligand
was contributed by the 50 oxygen of a second ribonucleotide
and represented the bridging oxygen of the phosphodiester to
be cleaved. The resulting pentacoordinate geometry of the
vanadate moiety is that of a distorted trigonal bipyramid and
is described by the authors as ‘‘an approximate mimic of the
transition state that is otherwise impossible to visualize ex-
perimentally’’ [40]. Comparison of the vanadate complex with
precursor and product structures revealed that the hairpin ri-
bozyme has apparently evolved to maximize the hydrogen
bonding interactions with the trigonal bipyramidal transition
state, and showed that the active site was essentially rigid, with
molecular motions during phosphodiester cleavage conﬁned to
320 D.R. Davies, W.G.J. Hol / FEBS Letters 577 (2004) 315–321the scissile phosphate itself and the ribose moiety that contains
the attacking nucleophile. These observations led to the pro-
posal that a common mechanism in RNA enzymes involves
transition state stabilization coupled with precise positioning
of substrate [40].
The versatility and power of enzyme–vanadate complexes
has also been demonstrated with a series of quaternary
complexes around vanadate in the active site of the DNA
repair enzyme human tyrosyl-DNA phosphodiesterase
(Tdp1). Tdp1 catalyzes the removal of tyrosine from a 30
phosphate at the end of a strand of DNA, a substrate that
occurs as a stalled intermediate in defective topoisomerase I–
DNA complexes. A transition state mimic for cleavage of this
substrate was visualized in a crystal structure where a trigonal
bipyramidal vanadate moiety had apical ligands composed of
an active site histidine side chain and a peptide tyrosine hy-
droxyl representing the attacking nucleophile and the leaving
group, respectively, and an apical ligand composed of the 30
hydroxyl of a single-stranded DNA oligonucleotide repre-
senting the non-cleaved portion of the phosphodiester [21]
(Fig. 1d). This structure was created by co-crystallization of a
mixture of 5.5 mg/ml Tdp1, 3 mM ‘‘activated’’ sodium or-
thovanadate from a 100 mM stock solution, 20 nmol/ll of a
topoisomerase-derived octapeptide, and 5 nmol/ll of a single-
stranded hexanucleotide. The transition state mimic appar-
ently self-assembled on the enzyme during crystallization. This
quaternary complex answered many questions about the
mechanism of Tdp1. First of all, the binding of vanadate to
His263 resolved a question about which of the two histidine
residues in the active site served as the nucleophile in the
initial cleavage step. The structure also conﬁrmed the sub-
strate binding mode and the observed conformation of the
substrate mimic provided strong evidence that the topoiso-
merase I–DNA complex must necessarily undergo some form
of degradation prior to cleavage by Tdp1 [21]. Follow-up
studies with the Tdp1 system have revealed that quaternary
complexes around vanadate can still be formed when the
DNA and peptide sequences are changed, and that the peptide
moiety can be replaced by non-peptide ligands [20]. The
modular nature of vanadate ligands in the active site has led
to interest in the use of vanadate complexes as a tool for the
development of structure-based inhibitors [20].5. Perspectives
Vanadate is a powerful tool for the formation of ap-
proximate transition state analogs for enzymes that perform
chemistry on phosphate. The visualization of such structures
is essential for understanding the dynamics of enzyme
mechanisms, and can often provide key insights into enzyme
structure and function. A survey of the Protein Data Bank
has revealed that structures of vanadate complexes have
been solved for a diverse subset of enzymes, encompassing
four of the six E.C. categories. The crystallization conditions
used to achieve these structures have likewise been diverse,
ranging in pH from 5.0 to 7.8. Furthermore, vanadate has
been successful in forming pentacoordiante transition state
mimics for enzymes that cleave phosphate monoesters
(generally thought to follow a ‘‘dissociative’’ mechanism) as
well as enzymes that cleave phosphate diesters (generally
thought to follow a more associative mechanism). Given theversatility of vanadate and the apparent ease with which
many of these complexes were obtained, it is somewhat
surprising that this method is not used more frequently. The
number of vanadate structures appears to fall far short of
the potential – for example, although there are over 300
entries in the Protein Data Bank for various phosphatases,
only two phosphatase–vanadate structures are deposited (a
third structure, for a phosphotyrosyl phosphatase has been
solved but is not currently in the PDB [43]). Given the
apparent versatility of vanadate and the ﬁrst-hand experi-
ence of these authors, we propose that the use of vanadate
to form transition state mimics for phosphoryl transfer en-
zymes is a component of the macromolecular crystallogra-
pher’s toolkit that could be brought to bear with greater
frequency and eﬃcacy.References
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